Malin is a publicly listed company investing in highly innovative life sciences companies.

We focus on oncology, immunology and genetic diseases where we believe innovative life science and healthcare technologies will deliver transformative treatments for patients.

Discover Our Story

Graphics

Our purpose is to deliver significant returns for shareholders and transformative outcomes for patients through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential.

Priority Assets


Our Priority Assets are the assets that we believe can deliver the most significant return for shareholders